Feb. 28 at 4:25 AM
$SPYR may have hit the motherload, this is bigger than we all thought.
”Spider venoms contain complex bioactive compounds; a company could develop drugs, pesticides, or diagnostic tools based on these molecules, then profit from licensing or product sales.”
at least one of the 8 legs this company has will dominate bio/pharma.
move over bat from wuhan, theres a new sherriff in town.